Metropolis Healthcare Ltd

METROPOLIS
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹9,002 cr, stock is ranked 346
Moderate RiskStock is 2.78x as volatile as Nifty
1,690.8068.45 (-3.89%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹9,002 cr, stock is ranked 346
Moderate RiskStock is 2.78x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
49.16
PB RatioPB Ratio
12.71
Dividend YieldDiv. Yield
0.45%
Sector PESector PE
32.23
Sector PBSector PB
4.77
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

62%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Metropolis Healthcare is a medical laboratory operator

Investor PresentationView older 

Feb 11, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020210.650.770.861.010.100.120.130.18
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 4.71%

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 18, 2022

Metropolis Healthcare Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Metropolis Healthcare Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Communication to shareholders as per Reg 30 
Announced OnMay 2, 2022

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Download

Cash Dividend 
Ex. DateFeb 21, 2022

Interim • Div/Share: ₹ 8

See all events